The transcription factor RUNX1 (AML) is essential for the commitment of MEPs towards the megakaryocytic cell lineage, by the activation of the megakaryocytic gene expression programme and the repression of the erythroid master regulator EKLF (KLF1). Here, KLF1 is linked to acute myeloid leukemia.